advertisement

WGA Rescources

Kim Y 35

Showing records 1 to 25 | Display all abstracts from Kim Y

95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Hsueh HT
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Song SJ
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Kim YC
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Choi KS; Han JC
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Pitha I
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Jee D
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Shin MD
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Jeoung JW
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Berlinicke CA; Chou RT
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Jo YJ; Kim JY
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Kimball E; Kimball E; Schaub J; Schaub J
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Kim KE
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Quillen S
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Kim ST
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Leo KT
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Lee JW; Lee TE
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Han H
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Lim DH
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Xiao A
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Kim CY
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Kim Y; Appell M
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Kim HW
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Rai U
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Park SW
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Kwon H
Pharmaceutics 2021; 13:

Issue 22-2

Change Issue


advertisement

Bioniko